Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine

The emergence of SARS-CoV-2 variants necessitates ongoing evaluation of vaccine performance. This study evaluates and compares the safety and immunogenicity of the Comirnaty and Spikevax monovalent XBB.1.5 COVID-19 vaccines in an elderly population. Altogether, 129 elderly individuals were recruited...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infection 2025-01, Vol.90 (1), p.106374, Article 106374
Hauptverfasser:	Mok, Chris Ka Pun, Tang, Yun Sang, Tan, Chee Wah, Chong, Ka Chun, Chen, Chunke, Sun, Yuanxin, Yiu, Karen, Ling, Kwun Cheung, Chan, Ken KP, Hui, David S.
Format:	Artikel
Sprache:	eng
Schlagworte:	JN.1 variant KP.2 variant Neutralizing antibodies Omicron XBB variant T-cell immunity XBB.1.5 vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!